This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second View: A deep dive into the concerns and treatment needs of monkeypox.
Ticker(s): BVNRYWho's the expert?
Institution: Kaiser Permanente
- Board Certified Infectious Disease Specialist practicing at Kaiser Permanente in Atlanta, Georgia.
- Has treated ~75 Monkeypox cases and is seeing 10-15 cases a week.
- Specializes in wound care and hyperbaric medicine; Familiar with Jynneos Vaccine and its efficacy in treatment.
Interview GoalWe will be discussing the level of concern and treatment need for this new outbreak. Also, we will learn the safety and efficacy of Bavarian Nordic's monkeypox vaccine.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
